Therapeutic Areas of Expertise



Dementia affects millions of people, more and more every year. We are proud to be leaders in Alzheimer’s research and are committed to finding a cure for this devastating disease.

Contact Us
Brain Scan
8+ Sites
8+ Specialists
400+ Trials
2,000+ Participants


  • Neurologists, Psychiatrists, and Psychologists
  • Experienced dedicated raters (ADAS-Cog, RBANS, CDR-S, CGIC, C-SSRS, Digit Span, Forward and Backward, FCSRT, MMSE, MoCA, ADL)
  • Psychometrics evaluation rooms
  • 1.5T and 3T MRI
  • fMRI
  • Open MRI
  • PET/CT
  • Lumbar puncture
  • Dedicated infusion suites
  • Overnight capabilities

Key Opinion Leaders

Cherian Verghese, MD

Cherian Verghese, MD

Cherian Verghese, MD, is a board-certified psychiatrist and an industry thought leader in Alzheimer’s disease who has dedicated his career to developing new medications to treat neuropsychiatric disorders. He served as Inpatient Director and Associate Chair of psychiatry at the Albert Einstein Medical Center in Philadelphia. In 2003, he founded Keystone Clinical Studies. He has been the Principal Investigator on over 130 clinical trials and has been instrumental in the FDA approval of medications in over 10 different indications. Dr. Verghese is also founding member of the CNS Summit.

Learn More
M. Reza Bolouri, MD

M. Reza Bolouri, MD

M. Reza Bolouri, MD, is a board-certified neurologist. Dr. Bolouri has over 20 years of research experience in Alzheimer’s disease.

Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.